Magnesium Hydroxide

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Magnesium Hydroxide

What is Magnesium Hydroxide? (INN: Mg(OH)2)

Property Description
Active ingredient Magnesium Hydroxide (Mg(OH)2)
Form Oral Liquid Suspension, Chewable Tablet, Tablet
Pharmacological class Antacid and Saline Laxative
Common use Relief of gastric acidity and occasional constipation
Origin Inorganic compound (derived from natural mineral brucite)

Magnesium Hydroxide is an inorganic compound with the chemical formula Mg(OH)2 that serves as an active ingredient in digestive medicines. The substance is derived from the natural mineral brucite and is chemically recognized as a weak base with low solubility in water, a property that necessitates its common formulation as a liquid suspension. It is primarily administered orally and is widely available in over-the-counter (OTC) products for both adults and children.

The most recognized pharmaceutical preparation is the oral liquid suspension, commonly known as Milk of Magnesia, though it is also available in solid forms such as chewable tablets. The preparation uses an aqueous vehicle because the active ingredient is practically insoluble, ensuring the Mg(OH)2 particles remain suspended.


What Type of Medicine is Magnesium Hydroxide Classified As?

Magnesium Hydroxide belongs to two distinct, high-level pharmacological classes simultaneously: it is classified as both an Antacid and a Saline Laxative. This dual identity is crucial to understanding its role in the body, as it provides relief for two separate digestive issues.

As an antacid, the medicine functions by engaging in a simple chemical reaction with stomach acid, a property that is clinically recognized for providing relief from gastric acidity-related discomfort. Separately, it is categorized as a saline laxative because the unabsorbed portion of the magnesium compound creates an osmotic effect in the intestinal tract. Oral magnesium salts increase the concentration of water in the intestinal lumen, which results in increased motility. This means the compound helps to alleviate a common scenario like occasional constipation by adding moisture and volume to intestinal contents.

Regulatory References

  1. NIH: Magnesium in Prevention and Therapy

What side effects are possible with Magnesium Hydroxide?

Possible Side Effects and Safety Information

Magnesium Hydroxide's safety profile is documented primarily around its effects on the digestive system and the potential for systemic absorption. All safety statements align with official government regulatory documents.


Adverse Reaction Classification

The most common adverse reactions are related to the gastrointestinal tract. Regulatory sources list disturbances in the Gastrointestinal Disorders system as key effects.

  • Common / Expected Effects: Diarrhea, nausea, vomiting, abdominal pain, and flatulence are the most frequently reported symptoms, consistent with the medicine's osmotic action as a saline laxative. Diarrhea is noted as being dose-related.

  • Serious Adverse Reactions (Very Rare): A serious safety concern is the risk of Hypermagnesemia (excess magnesium in the blood), which is categorized as Very Rare. This risk is predominantly associated with prolonged administration and existing renal impairment (kidney disease). Severe hypermagnesemia can affect the nervous and cardiovascular systems, potentially leading to muscle weakness, depressed reflexes, and cardiac arrhythmias.


Population-Specific Safety Considerations

Official labels include specific safety notes for individuals with conditions that affect magnesium clearance:

  • Renal Impairment: Patients with any degree of kidney disease are at a heightened risk of hypermagnesemia due to reduced ability to excrete magnesium.
  • Vulnerable Populations: Caution is also specifically noted for older adults and young children, particularly if dehydration or renal impairment is present, due to their increased susceptibility to magnesium accumulation.

High-Level Restrictions

The medicine is formally contraindicated in individuals with known hypersensitivity to the active substance. Regulatory notes also confirm that Magnesium Hydroxide can cause urine alkalinization, which may alter the excretion rate of other co-administered medicines.

Overdose and Emergency Response

Overdose and When to Seek Help

Magnesium Hydroxide overdose, which may occur with large ingestion or impaired elimination, results in a condition known as hypermagnesemia (excess magnesium in the blood). The severity of manifestations depends on the dose and the patient's underlying health, particularly renal function.

Documented Overdose Manifestations

Initial signs may include gastrointestinal symptoms like severe diarrhea, abdominal pain, nausea, and vomiting. As hypermagnesemia progresses, systemic signs of toxicity appear, including flushing, thirst, hypotension (low blood pressure), drowsiness, and loss of tendon reflexes.

Severe Outcomes and Emergency Action

Severe hypermagnesemia can lead to life-threatening complications such as muscle weakness, respiratory depression, cardiac arrhythmias, and potentially cardiac arrest or coma.

When to Seek Urgent Medical Help: Immediate medical help or contact with a Poison Control Center is required upon any suspicion of overdose or if signs of systemic toxicity (such as severe drowsiness, muscle weakness, or difficulty breathing) are observed.

Supportive Management

Treatment of severe hypermagnesemia generally involves administering the specific antidote, intravenous Calcium Gluconate, to counteract severe cardiovascular and respiratory effects. Supportive care includes ensuring adequate hydration to promote renal magnesium excretion. Dialysis may be required in cases of severe toxicity or in patients with renal impairment, who are at higher risk of toxicity.

Therapeutic Uses of Magnesium Hydroxide

Main Uses and Therapeutic Benefits

Magnesium hydroxide is a compound commonly utilized for its properties as an osmotic laxative and an antacid. It serves two primary functions based on its interaction with the digestive system.

Relief of Occasional Constipation

As a laxative, magnesium hydroxide works through an osmotic process. When it enters the intestines, it draws water from surrounding body tissues into the colon. This increase in water content serves several purposes:

  • Stool Softening: The accumulated water integrates with the stool, making it softer and easier to pass.
  • Stimulation of Bowel Movements: The increased volume within the intestines creates pressure against the intestinal walls, which naturally triggers the muscles to contract and move waste through the system.

This mechanism typically results in a bowel movement within a relatively short timeframe compared to bulk-forming laxatives.

Neutralization of Stomach Acid

In lower concentrations, magnesium hydroxide is used to manage symptoms associated with gastric acidity. It functions as an antacid through a direct chemical reaction in the stomach:

  • Acid Neutralization: The compound is alkaline, meaning it reacts with and neutralizes excess hydrochloric acid produced by the stomach. This reduction in acidity helps alleviate the burning sensation often associated with indigestion.
  • Symptom Management: By lowering the acid levels, it provides temporary relief from discomforts such as heartburn and sour stomach.

Summary of Benefits

The primary benefit of magnesium hydroxide is its dual-action capability to address both upper and lower gastrointestinal discomfort. It is valued for its predictable onset of action in treating constipation and its ability to provide rapid, localized relief from acid-related irritation without being absorbed extensively into the bloodstream.

Regulatory References

  1. NIH MedlinePlus overview on Magnesium Hydroxide

Eligibility and Restrictions for Use

The official regulatory profile for Magnesium Hydroxide defines eligibility based on organ function, acute pathology, and age group. The medicine is contraindicated for several populations due to the risk of toxicity or complication.

Contraindications and Restrictions

Absolute prohibition applies to individuals with severe renal impairment or kidney failure due to the high risk of magnesium accumulation. Use is also contraindicated in patients with pre-existing intestinal obstruction disorders, myocardial damage, or heart block.

Specific restrictions dictate that patients with non-severe kidney disease or those on a magnesium-restricted diet must use the product cautiously and consult a physician. Elderly patients are advised caution due to an increased risk of intestinal complications.

Age-Related Eligibility

Adults and adolescents (12 years and older) are generally eligible for use. However, use in children under 12 years is restricted: it is established as a laxative but generally not recommended as an antacid. Use in children under 2 years requires prior medical consultation.

Pregnancy and Lactation Status

For pregnancy, use is conditional on physician assessment where the benefit must outweigh the potential risk. Use during lactation (breastfeeding) is generally considered acceptable as minimal amounts are expected to affect the infant.

What should I know about interactions with other medicines?

The interaction profile for magnesium hydroxide is defined by its capacity to alter gastric pH and act as a source of absorbable magnesium, as stated in regulatory documents.

Interaction Category Documented Interacting Substances Official Constraint
Exposure Reduction Antibiotics (e.g., Ciprofloxacin, Tetracyclines), Bisphosphonates, Levothyroxine, Antivirals (e.g., Atazanavir), Iron salts Reduced absorption due to pH alteration and chelation (complex formation).
Timing Separation Affected oral medicines, Fluoroquinolones, Gabapentin General spacing of 2 to 3 hours is necessary; specific agents require at least 4 hours separation to mitigate reduced exposure.
Pharmacodynamic Effects Other magnesium preparations, Sodium Polystyrene Sulfonate, Quinidine Increased risk of hypermagnesemia and additive toxicity (e.g., increased Quinidine serum levels).

Contraindicated/Avoided Combinations: The combination with the Integrase Inhibitors Dolutegravir and Raltegravir is advised to be avoided. The regulatory status of co-administration with Nilotinib is also restricted.

Population-Specific Cautions: Patients diagnosed with renal impairment or kidney disease are at an officially documented increased risk of hypermagnesemia due to reduced elimination of the magnesium cation. This population requires specific consideration regarding potential magnesium accumulation.

Mechanism of Action

How Magnesium Hydroxide Works

Magnesium Hydroxide ( Mg( OH)2) exerts its action through two distinct physicochemical mechanisms in the gastrointestinal tract. In the stomach, the compound dissociates into magnesium cations ( Mg^2+) and hydroxyl anions ( OH^-). The hydroxyl anions function as a biological target for gastric hydrochloric acid ( HCl). Specifically, OH^- ions undergo a neutralization reaction with hydrogen cations ( H^+) from the HCl, resulting in the formation of water ( H2 O) and magnesium chloride ( MgCl2). This cascade leads to a localized increase in gastric pH.

The unabsorbed Mg^2+ ions proceed to the small intestine and colon. Here, Mg^2+ functions as an osmotically active solute within the intestinal lumen. The high concentration gradient established by the unabsorbed ions drives the passive transport of water from the systemic circulation into the intestinal lumen. This physiological consequence increases the intraluminal fluid volume, resulting in an enhanced hydrostatic pressure on the colon wall.

Dosage and Administration Information

How to Use Magnesium Hydroxide

Magnesium Hydroxide is administered exclusively via the oral route as an oral suspension or chewable tablet for its primary applications. Usage is determined by the intended purpose, which defines the dosing and frequency patterns.


Official Administration Guidelines

The dosage for this agent is classified into two distinct regimens based on the use. For acid indigestion (antacid use), doses commonly range from 400 mg to 1200 mg per symptomatic episode, taken as needed up to four times daily. Conversely, when used for constipation (laxative use), the standard dose is significantly higher, typically ranging from 2400 mg to 4800 mg, administered once daily or in divided doses. The maximum recommended daily intake may extend up to 7200 mg, depending on the specific product labeling.


Preparation and Duration

Proper administration of the liquid suspension requires the container to be shaken well immediately before measurement to ensure a homogeneous dose. Every dose, particularly for laxative use, should be followed by a full glass (8 ounces) of water or other liquid to support the drug's action. The medication is intended for short-term use, and labels specify that it should not be used for more than 7 days unless under the direction of a health professional.

Dosage for pediatric patients (e.g., ages 6 to 11 years) is generally reduced compared to the adult regimen, reflecting age-dependent dosing principles. Furthermore, the magnesium content requires caution in patients with renal impairment, as this status may affect the body's ability to handle magnesium.

Recent Clinical Evidence

Evidence for use as a Short-Term Treatment for Constipation

Magnesium Hydroxide was studied for its use in temporary, short-term constipation, which is a condition characterized by fluctuating or episodic manifestations. Research has explored this use in clinical studies and observational settings. These studies focused on outcomes related to systemic or functional imbalance, particularly the patterns of bowel movement frequency and stool consistency.

The findings from research suggest that, when used in research exploring how symptoms change over time, some studies monitored how individuals reported changes. This evidence contributes to understanding symptom patterns in conditions associated with acute or disruptive episodes.

However, the evidence is limited concerning long-term use. Follow-up durations were limited in many trials, meaning long-term effects are not fully established. Also, comparative evidence is lacking to fully understand how its effects differ from other options. Therefore, research provides context but not individual predictions for long-duration use.


Evidence for use as an Antacid in Heartburn Studies

Magnesium Hydroxide was evaluated in studies examining its use as an antacid for heartburn and acid indigestion. This research examined outcomes capturing phases of heightened symptom activity, particularly those outcomes related to physical discomfort felt in the chest or throat. The studies focused on outcomes reflecting daily functioning or activity level over defined time intervals.

Research describes how studies monitored patient-reported outcomes describing perceived discomfort. The findings describe patterns observed in the studies over short time intervals. This research provides insight into short-term changes when used for conditions involving periods of heightened symptoms.

Nevertheless, research has not fully established the extent of benefit for all forms of acid-related discomfort. The available data mainly show patterns related to temporary changes in symptom reports, but evidence quality varies across studies. For example, findings were mixed when examining how long data show patterns related to short-term patient-reported outcomes describing perceived discomfort lasted across different individuals and settings.


Long-term studies and follow-up

Research focusing specifically on the continuous or long-term outcomes of Magnesium Hydroxide is generally quite limited. Studies was observed in primarily during short timeframes to examine immediate effects, rather than durability of response. This section is focused on outlining what is known—and what is still uncertain—about using the product over an extended period.

The limited data show patterns related to temporary changes in symptom reports, but long-term effects are not fully established. Because follow-up durations were limited, there is a significant lack of research providing insights into outcomes reflecting durability of response or extended daily functioning. This means data are still emerging regarding the effects of prolonged use.


Evidence in special populations

Research has been studied for the effects of Magnesium Hydroxide in various special populations, but data for certain groups remain insufficient. Research explored outcomes related to systemic or functional imbalance in populations including those with reduced kidney function. Studies have also explored use in children, but often with sample sizes were modest, and results apply only to the populations studied.


What is still uncertain about Magnesium Hydroxide

Research contributes to the broader evidence landscape for Magnesium Hydroxide, but several gaps and uncertainties remain. The primary limitation is that many studies focus only on research exploring short-term symptom changes, meaning there is limited information for long-term outcomes or repeated use. The certainty remains low surrounding how individual patient factors, such as dietary habits or other health conditions, can influence the findings. Overall, this research highlights what is known — and what is still uncertain.

Key Studies & References

  1. Label: MAGNESIUM HYDROXIDE liquid (FDA DailyMed Monograph)

Frequently Asked Questions (FAQ)

Common questions about Magnesium Hydroxide (FAQ)


Q: Does Magnesium Hydroxide work right away for constipation?

According to the official product information, when used for occasional constipation, Magnesium Hydroxide generally produces a bowel movement within a range of 30 minutes to 6 hours after administration.

Q: How long does the laxative effect of Magnesium Hydroxide last?

The onset of the laxative effect generally begins within 30 minutes and up to 6 hours after a dose. As a short-acting treatment, the effect's duration is generally limited to this time frame.

Q: Does taking Magnesium Hydroxide affect my blood pressure?

Normal, occasional use does not typically affect blood pressure. However, regulatory documents note that in rare cases of severe magnesium accumulation, particularly in individuals with pre-existing kidney issues, serious effects such as hypotension (low blood pressure) and cardiac conduction changes have been documented.

Q: Is Magnesium Hydroxide the same as magnesium supplements like magnesium citrate?

No. Magnesium Hydroxide is officially classified as both an antacid and a saline laxative, meaning it neutralizes stomach acid. While other magnesium salts, such as magnesium citrate, share the saline laxative classification, Magnesium Hydroxide is distinct due to its additional indication for acid relief.

Q: Does Magnesium Hydroxide interact with common pain relievers like Tylenol (acetaminophen)?

Official drug interaction guidelines generally find no known interaction between Magnesium Hydroxide (Milk of Magnesia) and acetaminophen (the active ingredient in Tylenol). Official guidelines suggest spacing out administration of oral medications to mitigate absorption issues.

Q: Can I take Magnesium Hydroxide on an empty stomach?

Official labeling notes that taking each dose with a full glass of water or other liquid is recommended to support the drug’s intended action. The product information does not mandate taking it specifically with food.

Q: Does Magnesium Hydroxide have known interactions with common herbal supplements?

While specific herbal supplements are not universally listed on drug labels, official product information includes general warnings regarding concurrent use of other products, indicating that potential interactions should be reviewed by a health professional.

Q: Do official sources describe any connection between Magnesium Hydroxide and magnesium deficiency?

Official information primarily focuses on the safety risk of magnesium accumulation (hypermagnesemia), not deficiency. Although the drug contains magnesium, it is not indicated as a primary treatment for low magnesium levels in the body.

Q: Is it safe to use Magnesium Hydroxide if I am taking prescription medication for depression?

Magnesium Hydroxide, especially with long-term use, can affect electrolyte levels. Because some prescription medications, including those for depression, may also influence electrolytes, patients taking any prescription medication are advised in regulatory documentation to have potential risks of interaction or additive side effects reviewed by a health professional.

Q: How quickly does Magnesium Hydroxide relieve heartburn symptoms?

As a rapid-acting antacid, Magnesium Hydroxide is intended to quickly neutralize stomach acid to provide symptomatic relief from heartburn. Studies and official information indicate that antacids of this type generally begin working rapidly, often within minutes of administration.

Q: Can using Magnesium Hydroxide affect the results of blood tests?

Since Magnesium Hydroxide contains magnesium that can be absorbed by the body, excessive or prolonged use may potentially raise the magnesium level that appears on a standard blood test.

Q: Does Magnesium Hydroxide interact with common cold or allergy medicines?

Magnesium Hydroxide can reduce the absorption of many other oral medications by altering stomach acidity or forming complexes. To mitigate the risk of reduced absorption for other oral medications, regulatory guidelines often recommend spacing the administration of Magnesium Hydroxide by 2 to 4 hours.

Q: What are the general expectations for relief when using Magnesium Hydroxide for the first time?

Relief expectations differ by use. For heartburn, relief is expected rapidly, within minutes. For constipation, the laxative effect generally begins within a wider window, typically 30 minutes to 6 hours after the dose.

Q: Are there different flavors or formulations of the liquid product?

Official product information shows that the oral liquid suspension, often known as Milk of Magnesia, is manufactured in various versions that may include flavoring ingredients to improve the taste.

Q: Can I take Magnesium Hydroxide if I have diabetes?

While the drug itself is not strictly contraindicated for diabetes, official information advises that the use of this product should be reviewed by a health professional. This is important because some oral diabetes medications may interact with magnesium.

Q: What official information is available about the taste and texture of the liquid formulation?

The active ingredient, magnesium hydroxide, is a white, odorless powder that is practically insoluble. The final product is a suspension—meaning particles are suspended in a liquid base—and it is frequently manufactured with added flavor to enhance palatability.

Q: Can Magnesium Hydroxide affect the absorption of other vitamins or minerals?

Official regulatory information indicates that this product can interfere with the absorption of certain minerals, such as iron and zinc. This interference is typically due to the drug changing the stomach's pH or by forming complexes. To mitigate this interference, regulatory guidance recommends that the administration of the product be separated from mineral supplements.

Q: Can using Magnesium Hydroxide long-term cause dependence?

Regulatory labels state the product is not to be used for more than 7 days without consulting a health professional. Laxative dependence, described as a state where the body relies on the drug for function, has been associated with use that exceeds this recommended duration.

Q: Can Magnesium Hydroxide cause dehydration?

The drug's mechanism involves drawing water into the colon, and diarrhea is a common side effect that may lead to fluid loss. Regulatory warnings specifically reference the need for caution in vulnerable populations, such as young children and older adults, when dehydration is a possibility.

Q: Is Magnesium Hydroxide an electrolyte?

Magnesium Hydroxide is an inorganic compound that dissociates into magnesium ions ( Mg^2+) which are considered electrolytes. Official documents emphasize that prolonged use of the drug can lead to disturbances in the body's fluid and electrolyte balance.

Q: Does Magnesium Hydroxide lose effectiveness over time if used frequently?

Regulatory warnings emphasize that the product is intended for short-term use only. Using the product frequently or long-term may lead to a phenomenon known as laxative dependence, which is associated with the perceived loss of natural bowel function over time.

How should Magnesium Hydroxide be stored and disposed of?

How to Store and Dispose of Magnesium Hydroxide

Magnesium hydroxide must be stored under specific conditions to maintain its effectiveness, as required by official labeling.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F).
Protection Protect from freezing, which can cause separation of the suspension.
Container Keep in the original container and ensure it is tightly closed.
Safety The medicine must be kept out of the reach of children.

Disposal Instructions

Unused or expired product should be disposed of via a drug take-back program when available. If not, the medicine should be mixed with an undesirable substance, placed in a sealed bag, and discarded in the household trash, following local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Magnesium Hydroxide found in:

A-Z Index: